Systemic Combined Melatonin-Mitochondria Treatment Improves Acute Respiratory Distress Syndrome in the Rat
Cheuk-Kwan Sun,Fan-Yen Lee,Ying-Hsien Kao,Hsin-Ju Chiang,Pei-Hsun Sung,Tzu-Hsien Tsai,Yu-Chun Lin,Steve Leu,Ying-Chung Wu,Hung-I Lu,Yung-Lung Chen,Sheng-Ying Chung,Hong-Lin Su,Hon-Kan Yip
DOI: https://doi.org/10.1111/jpi.12199
2014-01-01
Journal of Pineal Research
Abstract:Despite high in-hospital mortality associated with acute respiratory distress syndrome (ARDS), there is no effective therapeutic strategy. We tested the hypothesis that combined melatonin-mitochondria treatment ameliorates 100% oxygen-induced ARDS in rats. Adult male Sprague-Dawley rats (n = 40) were equally categorized into normal controls, ARDS, ARDS-melatonin, ARDS with intravenous liver-derived mitochondria (1500 mu g per rat 6 hr after ARDS induction), and ARDS receiving combined melatonin-mitochondria. The results showed that 22 hr after ARDS induction, oxygen saturation (saO(2)) was lowest in the ARDS group and highest in normal controls, significantly lower in ARDS-melatonin and ARDS-mitochondria than in combined melatonin-mitochondria group, and significantly lower in ARDS-mitochondria than in ARDS-melatonin group. Conversely, right ventricular systolic blood pressure and lung weight showed an opposite pattern compared with saO(2) among all groups (all P < 0.001). Histological integrity of alveolar sacs showed a pattern identical to saO(2), whereas lung crowding score exhibited an opposite pattern (all P < 0.001). Albumin level and inflammatory cells (MPO+, CD40+, CD11b/c+) from bronchoalveolar lavage fluid showed a pattern opposite to saO(2) (all P < 0.001). Protein expression of indices of inflammation (MMP-9, TNF-alpha, NF-kappa B), oxidative stress (oxidized protein, NO-1, NOX-2, NOX-4), apoptosis (mitochondrial Bax, cleaved caspase-3, and PARP), fibrosis (Smad3, TGF-beta), mitochondrial damage (cytochrome C), and DNA damage (gamma-H2AX+) exhibited an opposite pattern compared to saO(2) in all groups, whereas protein (HO-1, NQO-1, GR, GPx) and cellular (HO-1+) expressions of antioxidants exhibited a progressively increased pattern from normal controls to ARDS combined melatonin-mitochondria group (all P < 0.001). In conclusion, combined melatonin-mitochondrial was superior to either treatment alone in attenuating ARDS in this rat model.